Fiche centre
Aarhus University Hospital
Aarhus — Denmark
Essais liés17clinical trials
VilleAarhuslocalisation
PaysDenmarklocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06523400
Essais cliniques associés
17| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MyoSense 360 | Myasthénie | Non applicable | NCT07323316 | HARMONY 360 — Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360 | RECRUITING |
| Selatogrel | Maladie coronarienne | Phase 3 | NCT04957719 | SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION |
| [O-15]-Water PET Myocardial Perfusion Imaging (MPI) | Maladie coronarienne | Phase 3 | NCT05134012 | RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) | COMPLETED |
| Physiology-guided NCL PCI | Maladie coronarienne | Non applicable | NCT05701358 | COMPLETE-2 — Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease | ACTIVE_NOT_RECRUITING |
| BioFreedom | Maladie coronarienne | Non applicable | NCT02915107 | OCT STEMI SOIX — The SORT OUT IX STEMI OCT Trial | COMPLETED |
| Short duration of aspirin and prasugrel | Maladie coronarienne | Phase 4 | NCT06718179 | SORT OUT DAPT — Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents | TERMINATED |
| Local ablative therapy (LAT) | Cancer | Non applicable | NCT06356779 | OLIGO-DK — Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease | RECRUITING |
| Tociliuzumab | Accident vasculaire cérébral | Phase 2/3 | NCT07870681 | Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE | NOT_YET_RECRUITING |
| WATCHMAN FLX LAAC Device | Accident vasculaire cérébral | Non applicable | NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING |
| Investigational PFO Closure Device | Accident vasculaire cérébral | Non applicable | NCT05069558 | OCCLUFLEX — Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion | ACTIVE_NOT_RECRUITING |
| Percutaneous transluminal angioplasty (PTA) | Insuffisance cardiaque | À vérifier | NCT07531966 | DAN-PTRAIII — Vascular Complications After Kidney Transplantation | RECRUITING |
| Mexiletine granules for prolonged-release oral suspension | Myopathies | Phase 3 | NCT06523400 | The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 | RECRUITING |
| Acoramidis | Alzheimer | Phase 3 | NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | RECRUITING |
| NMD670 | Myasthénie | Phase 2 | NCT06414954 | SYNAPSE-MG — Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis | RECRUITING |
| Del-desiran (AOC 1001) | Myopathies | Phase 3 | NCT07008469 | HARBOR-OLE — Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 | ENROLLING_BY_INVITATION |
| AOC-1020 | Myopathies | Phase 3 | NCT07038200 | FORTITUDE-3 — A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | RECRUITING |
| BHV-7000 | Épilepsie | Phase 2/3 | NCT06309966 | RISE 3 — Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy | ACTIVE_NOT_RECRUITING |